Karin Jeanne Jensen

20122019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2012 2019

Filter
Comment/debate
2018

Erratum to: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition (Nature Medicine, (2018), 24, 7, (968-977), 10.1038/s41591-018-0022-x)

Wong, G. S., Zhou, J., Bin Liu, J., Wu, Z., Xu, X., Li, T., Xu, D., Schumacher, S. E., Puschhof, J., McFarland, J., Zou, C., Dulak, A., Henderson, L., Xu, P., O’Day, E., Rendak, R., Liao, W. L., Cecchi, F., Hembrough, T., Schwartz, S. & 18 others, Szeto, C., Rustgi, A. K., Wong, K. K., Diehl, J. A., Jensen, K., Graziano, F., Ruzzo, A., Fereshetian, S., Mertins, P., Carr, S. A., Beroukhim, R., Nakamura, K., Oki, E., Watanabe, M., Baba, H., Imamura, Y., Catenacci, D. & Bass, A. J., Oct 1 2018, In : Nature Medicine. 24, 10, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Mitogen-Activated Protein Kinase Kinases
Medicine
Actins
Neoplasms